Who owns YS BIOPHARMA CO LTD?
- Ticker: LSBPW
- CUSIP Number: g9845f117
Tip: Access positions for across all investors
Analyze quarterly positions in Ys Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Ys Biopharma stock
Who bought or sold YS BIOPHARMA CO LTD this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
LMR Partners | 1.1M | $84k | 0% | Dec 2024 |
|
Valliance Asset Management | 750k | $50k | 0% | Sep 2024 |
|
BFAM Partners | 550k | $44M | 0% | Sep 2024 |
|
Jane Street | 498k | $40k | 0% | Dec 2024 |
|
Finepoint Capital | 490k | $49k | 0% | Dec 2024 |
|
Millennium Management | 425k | $34k | 100% | Dec 2024 |
|
Bracebridge Capital | 232k | $18k | 0% | Dec 2024 |
|
Ovata Capital Management | 150k | $15k | 0% | Dec 2024 |
|
Calamos Advisors | 146k | $15k | 0% | Dec 2024 |
|
Q Global Advisors | 131k | $10k | 0% | Dec 2024 |
|
Athos Capital | 129k | $45k | 0% | Dec 2024 |
|
Whitebox Advisors | 125k | $9.9k | 0% | Dec 2024 |
|
D. E. Shaw & Co | 100k | $9.9k | 0% | Dec 2024 |
|
Saba Capital Management | 97k | $7.7k | 0% | Dec 2024 |
|
Walleye Trading Advisors | 95k | $7.5k | -5% | Dec 2024 |
|
Cantor Fitzgerald, L. P. | 77k | $5.1k | 0% | Sep 2024 |
|
Deutsche Bank Aktiengesellschaft | 75k | $6.0k | 0% | Dec 2024 |
|
Clear Street | 48k | $3.0k | -3% | Sep 2024 |
|
Meteora Capital | 25k | $1.7k | 0% | Sep 2024 |
|
SkyView Investment Advisors | 12k | $999.999000 | 0% | Sep 2024 |
|
Ancora Advisors | 5.1k | $400.970000 | 0% | Dec 2024 |
|
HGC Investment Management | 5.0k | $397.000000 | 0% | Dec 2024 |
|
Who sold out of Ys Biopharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Highbridge Capital Management | Sep 2024 | 266k | $13k |
Cowen And Company | Sep 2024 | 213k | $14k |
Two Sigma Securities | Sep 2024 | 17k | $1.2k |